Chinese cancer therapy startup B.H. Med has closed 500 million yuan ($78.1 million) in a Series C round, while pet product brand CHOWSING has raised nearly 400 million yuan ($62.4 million) in a Series B+ round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
